Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on L 1. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Solve high-cost challenges in iclaprim synthesis. New acetic acid method replaces expensive cerium reagents, cuts production costs by 70%, and ensures >98% purity for scalable API manufacturing.
Discover how visible light-driven catalysis enables 80-90% yields with 90-99% ee for chiral alpha-unnatural amino acids, eliminating costly chiral resolution steps in drug development.
Discover how visible light-driven copper catalysis eliminates chiral resolution steps, achieves 90-99% ee, and reduces production costs for non-natural amino acid derivatives in pharmaceutical synthesis.
Solve high-cost, hazardous 1,2,4-triazine synthesis with this air-ambient, metal-free method. Achieve 65-87% yields without heavy metal catalysts or inert conditions. Reduce supply chain risks and production costs for your API development.
Solve lenvatinib impurity challenges with 98% purity, 80% yield. Our CDMO expertise ensures stable supply for pharma quality control.
Solve supply chain risks with this mild, high-yield palladium-catalyzed route for benzodihydrofuran intermediates. 80%+ yields, broad functional group tolerance, and scalable to 100MT/yr.
Solve supply chain risks with this green synthesis method for quinone thiazole compounds. No toxic oxidants, high yields, and simple scale-up for pharmaceutical intermediates.
Discover how copper-catalyzed oxidative coupling eliminates costly raw material steps and complex equipment for alpha-carbonyl amide production. Scale with 75-90% yields.
Solve low-yield and low-purity issues in trans-2-aminocyclohexanol production. This patent's 2-methoxyphenylacetic acid resolution method achieves >99%ee and 67% yield, reducing costs for pharma intermediates.
Solve transition metal contamination risks in thio-substituted imidazole synthesis. Our CDMO expertise scales this iodine-catalyzed method to 100MT/yr with >99% purity and consistent supply chain stability.
Solve complex synthesis challenges with this efficient Pd-catalyzed method. Achieve 80-95% yields, broad substrate tolerance, and simplified scale-up for drug development.
Solve low-yield indole synthesis challenges with this novel palladium-catalyzed method. Achieve 89% yields, mild conditions, and green processing for stable API supply chains.
Discover how asymmetric Povarov reaction with cobalt catalysts enables high-yield, enantioselective synthesis of chiral tetrahydroquinolines for drug development.
Solve supply chain risks in amide synthesis: New molybdenum carbonyl method eliminates toxic CO gas, uses cheap nitroarenes, and achieves high yields for pharma intermediates.
Discover a novel metal-free synthesis for pyrido[1,2-a][1,3,5]-triazin-4-one that eliminates heavy metal waste, reduces production costs, and streamlines your supply chain for pharmaceutical intermediates.
Solve multi-step synthesis challenges with rhodium-catalyzed asymmetric [4+1] cyclization. 91% yield, 95% ee, and mild conditions for stable API intermediates. Contact for CDMO solutions.
Solve supply chain risks with metal-free 5-trifluoromethyl-1,2,4-triazole synthesis. No catalysts, low cost, and green chemistry for API production. Request samples today.
Discover a metal-free, high-yield method for chiral 1,3-diamine with >97:3 dr. Reduce costs and supply chain risks in pharmaceutical synthesis.
Solve supply chain risks with 90%+ yield 3-chloro-4-amino maleimide synthesis. Copper-catalyzed, oxygen-tolerant process eliminates expensive anhydrous equipment. Contact for custom manufacturing.
Discover how photocatalytic N-alpha arylation eliminates HAT reagents, reduces costs, and achieves 99% purity for pharmaceutical intermediates. Scale to 100 MT/annual with CDMO expertise.